Epidemic history and baseline resistance to NS5A-specific direct acting drugs of hepatitis C virus in Spain

Hepatitis C virus (HCV) infection remains a global health problem. Previously, the prevalence of NS5A resistance-associated substitutions (RASs) to elbasvir, a new direct-acting antiviral (DAA) against the NS5A viral protein was assessed by our group before its introduction into clinical use in Spai...

Descripción completa

Detalles Bibliográficos
Autores principales: Palladino, Claudia, Ezeonwumelu, Ifeanyi Jude, Mate-Cano, Irene, Borrego, Pedro, Martínez-Román, Paula, Arca-Lafuente, Sonia, Resino, Salvador, Taveira, Nuno, Briz, Verónica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398927/
https://www.ncbi.nlm.nih.gov/pubmed/32747734
http://dx.doi.org/10.1038/s41598-020-69692-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398927/
https://www.ncbi.nlm.nih.gov/pubmed/32747734
http://dx.doi.org/10.1038/s41598-020-69692-7

Ejemplares similares